Today's breast cancer news is short and sweet.
Celery and parsley drew a lot of media attention today. Several sources covered a study which found that apigenin, which is found in celery and parsley, and to a lesser extent in apples, oranges and nuts, hindered the development of tumor blood vessels in animal studies. Researchers noted that while apigenin delayed tumor growth, it did not stop the initial development of breast cancer cells. Also, ideal amounts for humans are still unknown.
Aromatase inhibitors, anastrazole (Arimidex), letrozole (Femara) and exemestane (Aromasin), were also in the news. According to a study from Washington University in St. Louis, aromatase inhibitor therapy before breast cancer surgery reduces mastectomy rates. Of 159 women who were told they needed mastectomies, 81 were able to instead have breast-conserving surgery after 16 weeks on aromatase inhibitors. Of 4 women who were originally not candidates for surgery at all, after aromatase inhibitor treatment, three were able to have breast-conserving surgery, and one underwent a mastectomy.
Please check back tomorrow for more breast cancer news. Until then, you can follow me on Twitter (@ann_latestbc) for more updates throughout the day.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment